Drug
Anavex3 71
Anavex3 71: highest development phase Phase 2, developed by Anavex Life Sciences. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Anavex Life Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| ANAVEX3-71 oral capsules NCT06245213 | Phase 2 | Schizophrenia |
| ANAVEX3-71 NCT04442945 | Phase 1 | Healthy |
Latest
No recent events.
Follow Anavex3 71 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.